Holen Sie sich die Stockscreener-App
134.92
1.31%
1.75
Handel nachbörslich:
135.00
0.08
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$133.17
Offen:
$132.41
24-Stunden-Volumen:
6.02M
Relative Volume:
1.14
Marktkapitalisierung:
$234.01B
Einnahmen:
$41.95B
Nettoeinkommen (Verlust:
$13.40B
KGV:
17.64
EPS:
7.65
Netto-Cashflow:
$6.49B
1W Leistung:
+3.30%
1M Leistung:
+15.52%
6M Leistung:
+21.12%
1J Leistung:
+14.47%
1-Tages-Spanne:
$132.41
$135.41
1-Wochen-Bereich:
$128.25
$135.41
52-Wochen-Spanne:
$99.71
$135.41
Abbott Laboratories Stock (ABT) Company Profile
Firmenname
Abbott Laboratories
Sektor
Branche
Telefon
(224) 667-6100
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Vergleichen Sie ABT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-08 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-30 | Herabstufung | Edward Jones | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-21 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Bestätigt | Barclays | Overweight |
| 2023-04-20 | Bestätigt | Bernstein | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Raymond James | Outperform |
| 2023-04-20 | Bestätigt | UBS | Buy |
| 2023-04-20 | Bestätigt | Wolfe Research | Underperform |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-27 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-27 | Bestätigt | Morgan Stanley | Overweight |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-27 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-01-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-06-01 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-02-07 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-11-30 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-01-30 | Bestätigt | Citigroup | Neutral |
| 2018-01-25 | Bestätigt | Stifel | Buy |
| 2018-01-25 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-10-19 | Bestätigt | Stifel | Buy |
Alle ansehen
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Widespread Damage Warrants Caution; Abbott Labs, Tradeweb, ICE In FocusVideoIBD - Investor's Business Daily
Abbott (ABT) Gains As Market Dips: What You Should Know - Yahoo Finance
ABBOTT LABORATORIES SEC 10-K Report - TradingView
Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable May 15 to Shareholders of Record April 15 - Marketscreener.com
Abbott Declares 405th Consecutive Quarterly Dividend - Yahoo Finance
Abbott stock hits 52-week high, reaches $134.46 - Investing.com
Point of Care Diagnostic Market to grow at a CAGR of 7.5% (2024 – 2030): Wissen Research - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Sold by Paradigm Asset Management Co. LLC - MarketBeat
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Bradley Foster & Sargent Inc. CT Grows Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cordatus Wealth Management LLC Acquires Shares of 23,574 Abbott Laboratories (NYSE:ABT) - MarketBeat
Nicholson Wealth Management Group LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Principal Securities Inc. Acquires 8,389 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Meitav Investment House Ltd. Reduces Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Advyzon Investment Management LLC Acquires New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Americana Partners LLC Sells 2,006 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
D.A. Davidson & CO. Increases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Strategic Financial Concepts LLC Takes $316,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lateral Flow Assay Market Top PlayersAbbott Laboratories - openPR
Kornitzer Capital Management Inc. KS Purchases 9,314 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Ramsay Stattman Vela & Price Inc. Purchases 6,346 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Reaches New 52-Week HighHere's Why - MarketBeat
ING Groep NV Sells 99,117 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Boston Financial Mangement LLC Decreases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Parcion Private Wealth LLC Buys 2,161 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Handelsbanken Fonder AB Reduces Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ieq Capital LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Corps Capital Advisors LLC Takes Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Bioelectric Medicine Market Key Players AnalysisAbbott - openPR
bLong Financial LLC Buys New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Private Advisor Group LLC Acquires 90,662 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Alberta Investment Management Corp Purchases 80,435 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Global Retirement Partners LLC Has $6.63 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
DSM Capital Partners LLC Acquires 370,049 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Atlas Legacy Advisors LLC Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Atria Wealth Solutions Inc. - MarketBeat
Bank of Jackson Hole Trust Purchases New Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
10,812 Shares in Abbott Laboratories (NYSE:ABT) Purchased by GAM Holding AG - MarketBeat
MOKAN Wealth Management Inc. Makes New $2.36 Million Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories - Yahoo Finance
Callahan Advisors LLC Buys 10,022 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Buckingham Capital Management Inc. Sells 24,982 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Lifted by Venturi Wealth Management LLC - MarketBeat
Diabetic Retinopathy Market Projected To Witness Substantial Growth 2025-2032:Abbott Laboratories, Novartis - EIN News
Abbott Laboratories (NYSE:ABT) Hits New 1-Year HighWhat's Next? - MarketBeat
Medical Nutrition Market Top Players- Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc. - openPR
Sawgrass Asset Management LLC Cuts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Attessa Capital LLC Takes $295,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Rhumbline Advisers Sells 28,139 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Finanzdaten der Abbott Laboratories-Aktie (ABT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
2.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):